Evidence map›Paper›PMID 38544503›Full record

ArticleACS applied nano materials2024

Biocompatible Upconverting Nanoprobes for Dual-Modal Imaging and Temperature Sensing.

Egle Ezerskyte, Augustas Morkvenas, Jonas Venius, Simas Sakirzanovas, Vitalijus Karabanovas, Arturas Katelnikovas, Vaidas Klimkevicius

Abstract read
In one paragraph

Article in ACS applied nano materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Egle EzerskyteInstitute of Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.
Augustas MorkvenasBiomedical Physics Laboratory, National Cancer Institute, Baublio 3b, LT-08406 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-0179-715X
Jonas VeniusBiomedical Physics Laboratory, National Cancer Institute, Baublio 3b, LT-08406 Vilnius, Lithuania.
Simas SakirzanovasInstitute of Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.
Vitalijus KarabanovasBiomedical Physics Laboratory, National Cancer Institute, Baublio 3b, LT-08406 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-5029-8840
Arturas KatelnikovasInstitute of Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-3295-8366
Vaidas KlimkeviciusInstitute of Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.ORCID https://orcid.org/0000-0001-9463-4968

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demand for multimodal nanomaterials has intensified in recent years driven by the need for ultrasensitive bioimaging probes and accurate temperature monitoring in biological objects. Among the different multimodal nanomaterials that have been extensively studied in the past decade, upconverting nanoparticles are among the most promising. In this paper, we report the synthesis of upconverting nanoparticles with complex core-shell compositions, capable of being excited by 808 or 980 nm laser irradiation and exhibiting a good MRI response. The synthesized nanoparticles also demonstrated high colloidal stability in both aqueous and biological media as well as temperature-sensing capabilities, including the physiological range. Furthermore, the upconversion nanoparticles exhibited significantly lower cytotoxicity for HEK293T cells than the commercially available MRI contrast agent Gd-DTPA.

Identifiers

PMID38544503
PMCPMC10964196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.